Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Fidelity National Financial
FNF
$13.9B
| $98.6M | 0.05% |
3,345,078
+1,300,972
| +64% | +$35.8M |
|
352
Schwab 5-10 Year Corporate Bond ETF
SCHI
$11.5B
| $98.2M | 0.05% |
3,754,796
+111,780
| +3% | +$2.82M |
|
353
Workday
WDAY
$39.6B
| $97.7M | 0.05% |
521,602
-2,836
| -0.5% | -$458K |
|
|
CERN
354
DELISTED
Cerner Corp
CERN
| $97.7M | 0.05% |
1,425,131
-20,106
| -1% | -$1.38M |
|
355
Kraft Heinz
KHC
$30.7B
| $97.6M | 0.05% |
3,060,765
-80,460
| -3% | -$2.42M |
|
356
Aptiv
APTV
$12B
| $97.5M | 0.05% |
1,251,202
+42,582
| +4% | +$2.93M |
|
357
McCormick & Company Non-Voting
MKC
$13.7B
| $97.2M | 0.05% |
1,083,524
+4,750
| +0.4% | +$391K |
|
358
Zebra Technologies
ZBRA
$14B
| $96.9M | 0.05% |
378,528
-11,202
| -3% | -$2.63M |
|
359
Copart
CPRT
$27B
| $96.6M | 0.05% |
4,639,324
+16,724
| +0.4% | +$336K |
|
360
A.O. Smith
AOS
$8.29B
| $96.3M | 0.05% |
2,043,194
+1,116,532
| +120% | +$48.8M |
|
361
Align Technology
ALGN
$12.1B
| $95.8M | 0.05% |
349,050
-1,405
| -0.4% | -$316K |
|
362
Edison International
EIX
$28.2B
| $95.8M | 0.05% |
1,763,097
+65,231
| +4% | +$3.75M |
|
363
Carrier Global
CARR
$51B
| $95.6M | 0.05% |
+4,301,458
| New | +$79.9M |
|
364
Hewlett Packard
HPE
$63.4B
| $95.2M | 0.05% |
9,788,539
+242,464
| +3% | +$2.38M |
|
365
Hershey
HSY
$35.5B
| $94.7M | 0.05% |
730,803
-602,398
| -45% | -$81M |
|
366
Jack Henry & Associates
JKHY
$10.9B
| $94.6M | 0.05% |
514,193
+2,200
| +0.4% | +$383K |
|
|
PPL
367
PPL Corp
PPL
$26.5B
| $94.6M | 0.05% |
3,661,738
-23,346
| -0.6% | -$607K |
|
368
UDR
UDR
$12.3B
| $94.5M | 0.05% |
2,529,374
-1,516,091
| -37% | -$56.6M |
|
369
Ametek
AME
$55.4B
| $94.3M | 0.05% |
1,055,392
-130,671
| -11% | -$11M |
|
370
Incyte
INCY
$24.2B
| $94.1M | 0.05% |
905,426
-38,600
| -4% | -$3.72M |
|
371
Ingersoll Rand
IR
$32.6B
| $93.9M | 0.05% |
3,338,548
-72,343
| -2% | -$2.04M |
|
372
Moderna
MRNA
$21.8B
| $93.5M | 0.05% |
1,456,015
+438,140
| +43% | +$24M |
|
373
Corteva
CTVA
$52.6B
| $93.3M | 0.05% |
3,482,029
-71,275
| -2% | -$1.85M |
|
374
Alnylam Pharmaceuticals
ALNY
$27.5B
| $93.3M | 0.05% |
629,644
+18,825
| +3% | +$2.54M |
|
375
Steris
STE
$22.3B
| $92.9M | 0.05% |
605,328
+1,265
| +0.2% | +$193K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.